ROS-responsive thioketal nanoparticles delivering system for targeted ulcerative colitis therapy with potent HDAC6 inhibitor, tubastatin A
Article in European Journal of Pharmaceutical Sciences (July 2024)
The most recent citing publications are shown below. View all 57 publications that cite this research output on Dimensions.
Article in European Journal of Pharmaceutical Sciences (July 2024)
Article in Frontiers in Bioengineering and Biotechnology (July 2024)
Article in Biomacromolecules (June 2024)